Evaluation of knee function and safety after treatment of knee articular cartilage damage with iPS-cell-derived cartilage.

JRCT ID: jRCT1050220051

Registered date:16/06/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Damage of articular cartilage of the Knee
• Date of first enrollment: 16/06/2022
• Target sample size: 4
• Study type: Observational

Outcome(s)

• Primary Outcome: Evaluation of clinical outcomes of patients who received treatment with iPS-cell-derived cartilage for at least one year postoperatively.
• Secondary Outcome: Evaluation of safety of patients who received treatment with iPS-cell-derived cartilage for at least one year postoperatively.

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients who received and completed knee treatment with iPS-cell-derived cartilage.

Exclude criteria

Patients whom the doctors considered inappropriate for the study.
1) Patients with new-onset systematic diseases unrelated to the surgery that can not come to the hospital..
2) Patients who have difficulty coming to the hospital due to relocation.
3) Patients with new-onset psychiatric disorders that may influence the conduct and evaluation of this study.

Related Information

• Primary Sponsor: Matsuda Shuichi